v3.26.1
Goodwill and Intangible Assets (Additional Information) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
May 31, 2023
Dec. 31, 2022
Goodwill [Line Items]              
Goodwill $ 17,905   $ 17,905   $ 17,905    
Amortization expense 6,600 $ 6,500 13,180 $ 13,022      
Future amortization expense, remainder of 2026 13,400   13,400        
Future amortization expense, 2027 26,600   26,600        
Future amortization expense, 2028 26,600   26,600        
Future amortization expense, 2029 26,600   26,600        
Future amortization expense, 2030 26,600   26,600        
Future amortization expense, thereafter 49,200   49,200        
Goodwill, impairment losses     0   0    
Basilea              
Goodwill [Line Items]              
Upfront fee         4,000    
In-process research and development | XACDURO              
Goodwill [Line Items]              
Intangible assets pertain to product rights and developed technologies           $ 68,700  
In-process research and development | NUZOLVENCE              
Goodwill [Line Items]              
Intangible Asset, Finite-Lived, Acquired, Residual Value         $ 2,600    
Entasis              
Goodwill [Line Items]              
Goodwill             $ 11,500
Intangible assets pertain to product rights and developed technologies 106,700   106,700        
Entasis | Collaboration agreement              
Goodwill [Line Items]              
Intangible assets pertain to product rights and developed technologies 35,400   35,400        
Entasis | In-process research and development              
Goodwill [Line Items]              
Intangible assets pertain to product rights and developed technologies 71,300   71,300        
La Jolla Pharmaceutical Company              
Goodwill [Line Items]              
Goodwill             $ 6,400
Intangible assets pertain to product rights and developed technologies $ 151,000   $ 151,000